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Metabolic adaptation during Trypanosoma brucei’s life cycle
Trypanosoma brucei is a parasitic protist that causes significant health burden in sub-Saharan
countries endemic for the tsetse fly (Glossina spp.). During the bloodmeal of this insect vector,
the flagellate is transmitted to a variety of mammals, including humans, in which T. brucei
subs. gambiense and T. brucei subs. rhodesiense cause human African trypanosomiasis. During
its life cycle, T. brucei encounters and adapts to very diverse environments that differ in avail-
able nutrients. In the mammalian host, it exists in two major forms: the replicating long-slen-
der bloodstream form (LS-BSF) and the nondividing short-stumpy bloodstream form
(SS-BSF), the latter being pre-adapted to infect the insect vector [1]. While the BSF flagellates
primarily colonize the mammalian bloodstream and utilize the plentiful glucose for their
energy needs, they can also be found in the cerebrospinal fluid and in extracellular spaces of
several tissues, including the brain, adipose tissue, and skin [2,3]. In the insect vector, trypano-
somes occur in three major forms occupying different locations within the fly: the procyclic
form (PCF) resides in the midgut and proventriculus, while epimastigotes and metacyclic try-
pomastigotes are found in the salivary glands. During the fly’s bloodmeal, the latter form
infects the mammalian host. All three forms experience the glucose-poor and amino acid–rich
environment within the insect host. These drastic environmental changes encountered by T.
brucei during its development require significant morphological and metabolic changes and
adaptations [4,5].
The seminal work of Keith Vickerman led to the widely accepted model of a highly reduced
mitochondrial metabolism in the BSF [6,7]. Its single mitochondrion is incapable of oxidative
phosphorylation, and the active electron transport chain (ETC) is minimized to an alternative
pathway composed of glycerol-3-phosphate dehydrogenase (Gly-3-PDH) and the so-called
trypanosome alternative oxidase (AOX), which are linked to each other via a ubiquinol/ubi-
quinone pool [8]. The cytochrome-containing ETC is absent, and the mitochondrial trans-
membrane proton gradient is generated by the reverse activity of the FoF1-ATP synthase
complex at the expense of ATP [9–11]. The proton gradient across the mitochondrial inner
membrane is essential for protein import and transport of metabolites and ions so that vital
mitochondrial processes such as Fe-S cluster assembly [12], RNA editing and processing
[13,14], and cellular Ca2+ homeostasis are maintained [15,16]. The seemingly simplified bio-
chemical composition of the BSF organelle is underlined by its tube-shaped cristae-poor
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morphology, which is in striking contrast to the extensively reticulated cristae-rich mitochon-
drion of the PCF flagellates (Fig 1).
Because no indications have been obtained yet for the presence of a mitochondrial ATP-
producing system in the BSF, the entire cellular ATP pool is considered to be generated solely
by highly active glycolysis [17]. The glycolytic pathway in trypanosomes is unique in the sense
of sequestration of most of its enzymes within peroxisome-like organelles called glycosomes
[18]. Because the glycosomal membrane is impermeable to large solutes like NAD(H), the
essential reoxidation of glycolytically produced intraglycosomal NADH occurs by a shuttle
mechanism involving the oxidation of glycerol 3-phosphate to dihydroxyacetone phosphate by
the mitochondrial Gly-3-PDH [8].
Classical metabolic studies performed with trypanosomes purified from the blood of
infected rodents or with in vitro–cultured BSF supported the original hypothesis of a drasti-
cally simplified mitochondrial metabolism because under aerobic conditions, glucose is almost
completely catabolized to pyruvate that is excreted from the cells, indicating no need for the
mitochondrial enzymes of the tricarboxylic acid cycle. In the absence of oxygen or when AOX
is chemically inhibited, glycerol 3-phosphate is converted into glycerol that is produced in a
1:1 ratio with pyruvate [19,20]. Occasionally, the production of small amounts of other com-
pounds such as acetate, succinate, and alanine has been reported; however, these products
were instead attributed to the presence of a minor fraction of SS-BSF, a life cycle stage possess-
ing a more elaborated metabolism, with some traits characteristic of the metabolically complex
PCF [21].
In preparation for differentiation into PCF, the SS-BSF up-regulates a subset of mitochon-
drial and other proteins [21]. Moreover, these cells are metabolically active, motile, regulate
their internal pH [22], and excrete end products of glucose metabolism in ratios different than
Fig 1. Pie charts showing distribution of mass spectrometry–identified mitochondrial proteins in PCF (left)
and BSF (right) trypanosomes in terms of molecular functions. A total number of 1,195 and 956 proteins were
assigned to PCF and BSF mitoproteome, respectively. Different colors show different metabolic pathways and
categories. See also S1 Table. IFA-mito in PCF (left) and in BSF cell (right). BSF, bloodstream form; Hsp70, heat
shock protein 70; IFA-mito, immunofluorescence analysis of a mitochondrial Hsp70; mitoproteome, mitochondrial
proteome; PCF, procyclic form.
https://doi.org/10.1371/journal.ppat.1006679.g001
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the LS-BSF and PCF cells [21]. Differentiation of LS-BSF into SS-BSF is triggered by the
stumpy-inducing factor, and only pleiomorphic strains (e.g., AnTat 1.1) are able to sense this/
these yet-to-be-identified molecule(s) [23]. Extended passaging of pleiomorphic parasites in in
vitro cultures or by syringe between laboratory animals leads to the loss of responsiveness to
the stumpy-inducing factor and thus a failure to differentiate into SS-BSF. Consequently, such
strains (e.g., Lister 427) are called monomorphic, i.e., they exist only as a single form [24].
Interestingly, recent analyses employing the monomorphic LS-BSF strain Lister 427 showed
that, in addition to pyruvate, appreciable amounts of other carbon products (i.e., alanine, ace-
tate, and succinate) are excreted into the cultivation medium [25], implying a need not only
for cytosolic and glycosomal but also for mitochondrial enzymes thus far considered to be
absent (Fig 2). An additional metabolomics study involving heavy-atom isotope-labeled glu-
cose determined that a substantial fraction of succinate, as well as metabolic intermediates
such as malate and fumarate, are glucose-derived and originate from phosphoenolpyruvate via
oxaloacetate. Importantly, phosphoenolpyruvate carboxykinase, a glycosomal enzyme respon-
sible for this conversion, is essential for the BSF parasites [26]. Moreover, the majority of
excreted alanine and acetate is also derived from glucose. Alanine is most likely produced
from pyruvate by the transamination reaction of alanine aminotransferase, a potentially essen-
tial enzyme [27], while glucose-derived acetate is produced from pyruvate by the mitochon-
drial pyruvate dehydrogenase (PDH) complex and additional subsequent enzymatic steps. A
fraction of the acetate produced this way is exported to the cytosol for the de novo synthesis of
fatty acids, which is an essential process (Fig 2) [25]. In addition to glucose, the BSF seems to
uptake and metabolize amino acids such as cysteine, glutamine, phenylalanine, tryptophan,
and threonine [28], implying the existence of an unexpectedly complex metabolic network in
their mitochondrion.
The BSF mitoproteome
To map the BSF mitochondrial proteome (mitoproteome), we first used the available mass
spectrometry data of purified PCF mitochondria [29–37] in order to assemble a comprehen-
sive list of mitochondrial proteins. Next, we asked how many of these proteins were identified
in any mass spectrometry data obtained from BSF cells [38–43]. To our surprise, out of 1,195
constituents of the PCF mitoproteome, 956 were also identified in at least one study of the
BSF, suggesting that, when qualitatively measured, the corresponding mitoproteome is
reduced by only approximately 20% (Fig 1; S1 Table). The surprisingly high, approximately
80% overlap with the PCF mitoproteome might also be a consequence of the heterogeneity of
the examined BSF populations. The heterogeneity may be related to the experimental proto-
cols, the environmental variations (cells grown in vivo versus in vitro), or variations within the
cell cycle (e.g., ATP requirements vary between different cell cycle stages) as well as to the
form type (monomorphic versus pleiomorphic). Indeed, some authors analyzed monomor-
phic strains grown in vitro [40,41], and others examined the pleiomorphic AnTat 1.1 strain
grown either in immunosuppressed rats [43] or in vitro (S1 Table) [38]. Therefore, some
LS-BSF cells may have a mitochondrion that is close to the “classical” version, while a subset of
these flagellates may express an extended mitoproteome. However, no apparent differences
were detected between the mitoproteomes from the pleiomorphic and monomorphic BSF
cells, suggesting that, regardless of their status, a surprisingly large repertoire of mitochondrial
proteins is expressed in the BSF stage.
All proteins were then organized into groups based on their Kyoto Encyclopedia of Genes
and Genomes (KEGG) annotations. No striking qualitative differences were observed in the
categories “oxidative phosphorylation” and “core metabolic pathways” comprising many
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enzymes involved in the carbon, amino acid, and energy metabolism (Fig 1, S1 Table). Typical
examples are components of the tricarboxylic acid cycle and subunits of the ETC complexes,
most prominently of respiratory complexes III and IV (Fig 2, S1 Table). Nonetheless, when
quantitative information was available, these proteins were often present in much lower
amounts than in the PCF. While some of these proteins may not perform their expected func-
tion(s) under BSF steady state growth conditions, this finding strongly suggests that the para-
site is capable of swift alterations or adjustments of its metabolism in response to various
environments and differentiation cues. This ability can be exploited during environmental
changes, for example when the LS-BSF migrates from the peripheral blood circulation to other
Fig 2. Schematic representation of carbon source metabolism in the bloodstream form of T. brucei. Red arrows represent enzymatic steps that were
experimentally shown to be active in BSF. Green arrows represent enzymatic steps that might be active in BSF because the enzymes (in green) were identified
in BSF proteomic data. Glucose-derived metabolites (acetate, pyruvate, succinate, alanine, aspartate) are on a blue background. NADH molecules are on a
pink background. Dashed arrows indicate enzymatic steps for which no experimental proof exists. The glycosomal and mitochondrial compartments are
indicated. 2-OGDH, 2-oxoglutarate dehydrogenase; AAC, ADP/ATP carrier; AAT, amino acid transporter; ACH, acetyl-CoA thioesterase; AKCT, 2-amino-
3-ketobutyrate coenzyme A ligase; Ala TR, alanine transaminase; AOX, alternative oxidase; ASCT, acetate:succinate CoA-transferase; Asp TR, aspartate
transaminase; BSF, bloodstream form; cI, complex I (NADH:ubiquinone oxidoreductase); cII, complex II (succinate dehydrogenase); cIII, complex III
(cytochrome bc1 complex); cIV, complex IV (cytochrome c oxidase); cV, complex V (FoF1 ATPase); cyt, cytosolic; DHAP, dihydroxyacetone phosphate; FH,
fumarate hydratase (i.e., fumarase); FR, fumarate reductase; G3P, glyceraldehyde 3-phosphate; GluDH, glutamate dehydrogenase; gly, glycosomal; Gly3P,
glycerol 3-phosphate; Gly-3-PDH, glycerol-3-phosphate dehydrogenase; m, mitochondrial; MDH, malate dehydrogenase; PDH, pyruvate dehydrogenase;
PEP, phosphoenolpyruvate; PEPCK, phosphoenolpyruvate carboxykinase; PiC, phosphate carrier; ProDH, proline dehydrogenase.
https://doi.org/10.1371/journal.ppat.1006679.g002
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extravascular spaces (e.g., in adipose tissue, spinal and cerebral fluids) and during the differen-
tiation to SS-BSF. Therefore, the BSF trypanosomes may uptake different substrates from the
available nutrients according to their immediate needs and metabolize them via a variety of
pathways.
Complex metabolic pathways in the BSF mitochondrion: Does
presence equal activity?
The current metabolic model for BSF excludes a role of the mitochondrion in the ATP produc-
tion by either oxidative or substrate-level phosphorylation [44]. In contrast to this premise,
succinyl-CoA synthase (SCoAS), an enzyme responsible for substrate-level phosphorylation of
ADP to ATP, has been detected in BSF cells, and more importantly, its RNA interference
(RNAi)–mediated silencing produced a severe growth phenotype [45]. This enzyme can be
involved in two ATP-producing pathways. The first one includes activity of 2-oxoglutarate
dehydrogenase (2-OGDH) producing succinyl-CoA from 2-oxoglutarate that originates from
amino acids such as proline and glutamine or can result from transamination reactions by
mitochondrial alanine and aspartate transaminases (Fig 2). While all the enzymes involved in
these reactions were detected in the LS-BSF mitoproteome (Fig 2 and S1 Table), the activity of
2-OGDH remains contradictory because some authors failed to detect it in the pleiomorphic
cells [46], while others recorded its low activity in culture-adapted monomorphic LS-BSF cells
[47]. Puzzlingly, the 2-OGDH subunits E1 and E2 were shown to be essential in BSF not
because of their role in carbon metabolism but rather due to their moonlighting roles in glyco-
somes and mitochondrial DNA maintenance [46,48]. However, in an untargeted metabolo-
mics study using isotope-labeled glucose, up to 30% of excreted succinate remained unlabeled,
supporting its nonglucose origin [26] and making the occurrence of this substrate-level phos-
phorylation reaction even more plausible (Fig 2).
The second phosphorylation pathway includes the acetate:succinate CoA transferase/
SCoAS cycle that contributes to acetate production in the BSF mitochondrion. A substrate for
this reaction—acetyl-CoA—is produced by PDH, an enzymatic complex that is present and
active in the BSF mitochondrion [15,25]. Moreover, PDH was shown to be indispensable for
BSF cells but only in the absence of threonine because under these artificial conditions, PDH
was the only system supplying acetyl-CoA for the essential acetate production [25]. Nonethe-
less, the mitochondrial pyruvate transporter was demonstrated to be essential for BSF in vivo,
supporting PDH’s vital role for the parasite [49]. These results imply that the BSF mitochon-
drion may become an ATP producer under certain conditions, perhaps just for intramito-
chondrial needs (Fig 2).
The presence and potential activity of the aforementioned dehydrogenases that produce
NADH within the mitochondrion imply that the organelle would require reoxidation of this
cofactor. Several possible scenarios for such a capacity can be deduced from the available data
(S1 Table). Although complex I (NADH:ubiquinone oxidoreductase) was shown to be neither
essential for BSF nor contributing to the observed NADH:ubiquinone oxidoreductase activity
[50], it is still assembled in the BSF mitochondrion and may participate in NADH reoxidation
under certain conditions. Reoxidation of reduced NADH molecules can also be achieved by
the activity of the alternative dehydrogenase 2 (Ndh2), an enzyme shown to be important but
not essential for maintaining the mitochondrial redox balance [51]. Last but not least, another
scenario includes the activities of the mitochondrial malate dehydrogenase, fumarate hydra-
tase (i.e., fumarase), and NADH-dependent fumarate reductase, with all three being present in
the BSF mitoproteome (Fig 2, S1 Table). These enzymes reduce glucose-derived oxaloacetate
via malate and fumarate to succinate. Indeed, 3-carbon–labeled succinate was identified in an
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untargeted metabolomics study, implying that this pathway might be active [26]. Still, it should
be noted that it is so far impossible to discriminate between the mitochondrial, glycosomal,
and cytosolic derivations of this metabolite and that only a systematic deletion of the corre-
sponding enzymatic isoforms followed by metabolomics would illuminate the cellular com-
partment in which this glucose-derived succinate is produced. To sum up, the collective
activity of the aforementioned reoxidation enzymes is most likely responsible for the mito-
chondrial NADH regeneration. Possibly, RNAi silencing of the mitochondrial malate dehy-
drogenase and fumarate reductase in the background of complex I and Ndh2 null mutants
would shed light on the quantitative role of each of these enzymes in mitochondrial NADH
reoxidation.
The possible occurrence of the mitochondrial substrate-level phosphorylation reactions
raises an interesting question regarding the mitochondrial bioenergetics of BSF and questions
the origin of ATP that is needed by mitochondrial FoF1 ATPase in order to maintain the mito-
chondrial membrane potential. The classical model presumes that ATP is imported into the
organelle via the activity of the ATP/ADP carrier [52,53]. However, the available data—such as
low sensitivity of BSF to treatment with bongkreic acid, an inhibitor of this carrier—raise
some doubts about this assertion. Interestingly, the BSF does not respire when the mitochon-
drial transmembrane proton gradient is dissipated upon treatment with the FoF1 ATPase
inhibitor oligomycin or by addition of carbonyl cyanide-4-(trifluoromethoxy)phenylhydra-
zone (FCCP). However, when treated with bongkreic acid, which should halt the activity of
FoF1 ATPase by restraining its substrate, the parasite consumes oxygen at the same rate as
untreated cells [54,55]. On one hand, it is possible that the mitochondrial inner membrane
harbors another ATP/ADP carrier; on the other hand, it is a plausible speculation that, when
specific conditions emerge, the BSF mitochondrion has the capacity to employ its complex
enzymatic network to produce ATP by substrate-level phosphorylation to power the FoF1
ATPase.
Concluding remarks
Combined, the available data reveal that the metabolic flexibility and adaptability of the BSF
mitochondrion are much larger than appreciated so far. Mitochondrial metabolism appears to
be controlled at various levels; a developmental program seems to be a major contributor, but
recent advances in the field suggest that other cues may also play a role through fine-tuning
mechanisms. However, the triggers and signaling pathways of these mechanisms remain to be
identified. Furthermore, it should be realized that almost all metabolic studies have been per-
formed with strains well adapted to laboratory conditions. While the proteomic data do not
show any significant differences between the monomorphic and pleiomorphic strains, future
work combining proteomics and metabolomics with functional genomics should be extended
to the mitochondrion of trypanosomes isolated not only from blood but also from other tissues
to determine whether their metabolism is tissue specific and, if so, what is/are the mechanism
(s) that control(s) the changes. Therefore, the virtually unexplored array of pathways and
enzymes begs for attention because it may have important implications for drug target identifi-
cation and future novel chemotherapeutics. Moreover, a decreased morphological complexity,
which is apparently not reflected in metabolic complexity, is an interesting and novel phenom-
enon that can now be efficiently addressed with emerging, increasingly sensitive methods.
Supporting information
S1 Table. List of mitochondrial proteins that were identified in proteomic analysis of PCF
cells (columns F, G, and H) and of BSF cells (columns I, J, K, L, M, and N). The column
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color coding is green for PCF, dark grey for monomorphic BSF, and light gray for pleio-
morphic BSF cells.
1, identified; 0, not identified; BSF, bloodstream form; PCF, procyclic form.
(XLSX)
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